concerning audit quality control system. If the SEC Office still views that the applicant is unqualified, the applicant may object to the SEC Office’s decision and present more evidence to support the

Executive Officer of Charoen Pokphand Foods Public Company Limited.“In the present-day society, it is generally known that the growing use of plastic products increases plastic waste every year, and widely

of residences units participating in the Veranda Residence Pattaya rental program compared to the previous year which residence units had started to participate in the program in first quarter of 2018

: ________________________________________________________ 3) Home Regulator: _________________________________________________________ 4) Legal form of NRI CIS: Legal entity Unit trust Any other structure acceptable to participating jurisdictions 5) Type

Unit trust Any other structure acceptable to participating jurisdictions 5) Type of NRI CIS: (more than one answer is possible) Equity Fund Fixed Income Fund Multi-Asset Strategy Fund Money Market Fund

, the Company engaged an independent financial advisory to evaluate the fair value measurement of the investments by using income approach method and discounted cash flow to present value. As a result

the two languages, the Thai version shall prevail. The objective of this MD&A is to present the information and the explanation of financial status and operating results as of the date hereof. However

the major shareholder of CSL. The acquisition deal in total was Bt3.4bn. Since Feb-18, AIS started to fully consolidate CSL’s revenue and cost accordingly. At present, the revenue from CSL is grouped

subsidiaries engaged in businesses such as hotels and property management. We present the result of operations for such subsidiaries as discontinued operations for the years prior to the year in which these

shall prevail. The objective of this MD&A is to present the information and the explanation of financial status and operating results as of the date hereof. However, the information provided in this MD&A